Ghent (Belgium), 16 December 2025 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces it has received new funding from VLAIO, the Flemish Agency for Innovation & Entrepreneurship. The funding will support the RhizoScale project which aims to accelerate the scaling of Protealis’ highly innovative soybean seed coating MagNfix^TM, allowing farmers in Europe to easily grow high-yield, high-protein soybean in Europe.

Benjamin Laga, CEO of Protealis, reacted: “This VLAIO support is key to scaling both our team and production capacity as we bring our innovative soy seed coating, MagNfix™️, to market. It enables us to accelerate our commercial activities so European farmers can benefit sooner from an easy-to-use and highly effective seed coating that supports more reliable nitrogen fixation, higher yields, and increased protein content.”

Today, over 34 million tonnes of soy is imported annually[1] in Europe, mainly from Brazil, Argentina and the US. The growing food and feed markets make Europe heavily reliant on imported soy, and related import taxes. Cultivating soy locally in Europe has historically been difficult because of long daylight hours and the absence of natural Bradyrhizobium bacteria in European soils. Soybean plants need these bacteria to effectively extract atmospheric nitrogen from the air and fix it in the root nodules into a form the plant can use to grow and produce protein. Without these bacteria, soy delivers low yields.  

Over the past decade, soybean acreage in Europe has grown steadily, driven by the introduction of higher-performing varieties adapted to European growing conditions. Current soybean seed inoculation methods however still struggle to deliver consistent results at farm scale. Whether applied at the factory or on-farm, many existing approaches rely on bacterial strains that are not adapted to local soils, are difficult to store or transport, and are applied unevenly. In addition, most inoculants have a very limited shelf life: live bacteria must be applied within one to two days before planting or they rapidly lose effectiveness. These constraints make large-scale inoculation impractical and limit the yield and protein potential farmers can achieve.

Protealis’ seed coating technology[2] MagNfix^TM differentiates through the use of a unique local Bradyrhizobium bacteria strain that remains biologically active even in this temperate Western European climate. Most importantly, the coating will be offered as a ready-to-sow solution, replacing today’s cumbersome inoculation steps with a simple, farmer-ready approach. After several years of testing and field trials demonstrating consistent improvements in yield and protein content compared with existing inoculation products, Protealis is now ready to scale its solution. The company is expanding its team and preparing the industrial activities required to bring its unique seed coating technology into large-scale production.

Soybean production in Europe reached 3.00 million tons in 2024, making soy the leading plant protein crop before peas, faba beans and lupins[3]. Demand for locally grown, non-GMO soy continues to rise in Europe, driven by growth in plant-based food markets, sustainability targets, and high import costs. This trend aligns with Protealis’ mission: since its inception in April 2021, the company has rapidly built a portfolio of high-performance, early-maturing soybean varieties tailored to cooler northern and central European regions.

                                                                                                                   *** END ***

More information: 
Renate Degrave
Head of Communications and Marketing Protealis
renate.degrave@protealis.com | +32 471 53 60 64

 

About Protealis

Protealis develops superior plant protein seeds and seed technologies, optimized for the European soil and climate. Being at the forefront of sustainable agriculture, Protealis aims to empower European farmers with sustainable and resilient alternatives to traditional protein sources by developing legume seed solutions with enhanced crop yield and protein levels, while at the same time minimizing the ecological footprint. By addressing the growing demand for more plant-based protein sources, the company is committed to contribute to more sustainable food systems. Today, Protealis operates as a commercial-stage company with nine early-maturity soybean varieties currently on the market and registered in Belgium, France, Germany, and Ukraine. Ukraine represents a significant growth market, with soybean acreage projected to reach 2.3–2.4 million hectares and production forecast at 5.7–5.8 million tons in 2025 (Donau Soja, 2025). In parallel, the company is rapidly advancing its yellow pea breeding program within its development pipeline. The company is headquartered in the biotechnology cluster in Ghent, Belgium. More info on www.protealis.com, LinkedIn or facebook.

 

^{Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ("legitimate interest"). However, if you do not wish to receive further information about Protealis, email us at info@protealis.com and we will no longer process your details for this purpose. You can also find further details in our privacy statement on www.protealis.com.}

 ^{Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Protealis’ (‘the Company’) or, as appropriate, the Company directors' or managements' current expectations and projections concerning future events such as the Company's results of operations, financial condition, liquidity, performance, prospects, growth, strategies and the industry in which the Company operates. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.}